| P.I. Michael Emerman Started 8/89. |
![]() |
| Lab Manager: Lily Wu |
Emerman lab 6-03-07
Shari Kaiser MCB program. Started 6/03. Subject: Antiviral defenses to endogenous retroviruses.

Recent paper: Kaiser, S.M., Malik, H.S., and Emerman, M. Restriciton of an extinct retrovirus by the human Trim5a antiviral protein (2007) Science 316: 1756-1758.
Tsai-Yu Lin Pathobiology program. Started 6/04. Subject: Mechanisms of adaptation of primate lentiviruses to new hosts.

Recent paper: Lin, T-Y. , Emerman, M. (2006) Cyclophilin A interacts with diverse lentiviral capsids. Retrovirology 3: 70. Abstract/ Full Text
Molly OhAinle MCB program. Started 6/04. Subject: Evolution of function Apobec3 genes in primates.

Recent paper: OhAinle, M., Kerns, J.A., Malik, H.S., and Emerman, M. Adaptive Evolution and Antiviral Activity of the Conserved Mammalian Cytidine Deaminase APOBEC3H. J. Virol. (2006). J. Virol., 80: 3853-3862 Abstract / Full Text
Semih Tareen MCB program. Started 6/06. Subject: Identification of novel retroviral restriction factors
Melody Li Departmet of Microbiology. started 6/07. Subject: coming soon.
Masahiro Yamashita, Ph.D. Started 4/01. Subject: HIV infection of non-dividing cells.
Recent paper: Yamashita, M., and Emerman, M. The Cell Cycle Independence of HIV Infections is Not Determined by Known Karyophilic Viral Elements. (2005) PLoS Pathog 1 (3) e18: 170-178. Abstract / Full Text
Yegor Voronin, Ph.D. Started 10/03 (joint post-doc with Julie Overbaugh) Subject: Fitness differences between HIV/SIV strains
Recent paper: Voronin, Y., Overbaugh, J., and Emerman, M. SIV Variants that Differ in Pathogenicity Differ in Fitness under Rapid Cell-turnover Conditions. (2005) J. Virol. 79: 15091-15098. Abstract / Full Text
Vineet KewalRamani
6/90-6/96; Ph.D. in MCB and Microbiology Programs; Thesis title: Functional Analyses of Virion Associated Proteins Encoded by Immunosuppressive Retroviruses. Currently, Chief, Model Development Section, NCI-Frederick Cancer Research and Development.
Gina Stivahtis
8/94-8/99 Ph.D. in MCB program; Thesis Title: Evolution of Vpr function in Primate Lentiviruses. Currently, Attorney-at-Law.
Robb Lowe
8/96-12/02 Ph.D. in MSTP program (joint with Ake Lernmark at Dept. of Medicine, UW); Thesis Title: The role of AU repeats in the CTLA-4 gene in Type I Diabetes Susceptibility. Currently, Pediatrics Residency in Cleveland, OH.
Nicolas Manel
8/00-8/01 D.E.A. before returning to graduate school with Marc Sitbon in Montpellier, France. Project; Biochemical analysis of Vpr/Vpx Currently, Post-doctoral fellow, laboratory of Dan Littman, NYU.
Carol Deminie, Ph.D,
11/90-7/94; Subject: Replication and assembly of chimeric retroviruses. Currently, Staff Scientist at Bristol-Myers Squib, Wallingford, CT.
Paul Lewis. M.D.
8/91-8/93; Pediatric Infectious Disease Fellow; Subject: HIV infection of non-dividing cells. Currently, Adjunct Professor of Pediatrics, Oregon Health Sciences University and Public Health Officer in the Oregon Department of Human Services Acute and Communicable Diseases.
Peter Gallombardo, Ph.D.
7/93-4/95; Subject: HIV-2 replication in non-dividing cells; deceased 8/95.
Wei-Chun Goh, M.D., Ph.D.
7/93-1/03; Infectious disease fellow; Subjects: Biochemical analysis of Vpr and genetic analysis of an exposed HIV seronegative cohort. Currently, Assistant Professor, Department of Infectious Disease, Tufts University Medical School.
Steven Bartz, Ph.D.
2/95-7/01; Subject: Mechanisms of HIV-induced protection from apoptosis and induction of apoptosis. Currently, Senior Research Biologist, Rosetta Inphamatics-Merck, Seattle, WA.
Marie Vodicka, Ph.D.
6/95-8/02; Subject: Intracellular trafficking of HIV. Currently, Senior Director, Biologics and Biotechnology, Pharmaceutical Research and Manufacturers of America.
Rahm Gummuluru, Ph.D.
11/96-12/02; Subject: Mechanisms of HIV transmission between cells. Currently, Assistant Professor, Department of Microbiology, Boston University Medical School.
Aleida Perez, PhD.
11/98-10/00; Subject: Role of HIV infection of non-dividing cells. Currently, Staff Scientist, Sanganmo Biosciences, Inc., Richmond, CA.
Timothy Dellit, M.D.
6/02-6/03; Infectious disease fellow; Subject: HIV population biology. Currently, Director, Antimicrobial and Antimicrobial Resistance Management, Harborview Medical Center; Assistant Professor, Division of Infectious Diseases, University of Washington, Seattle.